Your browser doesn't support javascript.
loading
Effects of brain mineralocorticoid receptor blockade on blood pressure and renal functions in DOCA-salt hypertension.
Rahmouni, Kamal; Sibug, Rosana M; De Kloet, E Ronald; Barthelmebs, Mariette; Grima, Michèle; Imbs, Jean Louis; De Jong, Wybren.
Affiliation
  • Rahmouni K; Institut de Pharmacologie, Faculté de Médecine, Université Louis Pasteur, Strasbourg, France. kamal-rahmouni@uiowa.edu
Eur J Pharmacol ; 436(3): 207-16, 2002 Feb 02.
Article in En | MEDLINE | ID: mdl-11858800
In normotensive rats, we have previously demonstrated a role of brain mineralocorticoid receptors in blood pressure and renal function control. In the present study, the coordinate cardiovascular and renal effects of brain mineralocorticoid receptor blockade were examined by intracerebroventricular (i.c.v.) administration of a selective mineralocorticoid receptor antagonist (RU28318; 3,3-oxo-7 propyl-17-hydroxy-androstan-4-en-17yl-propionic acid lactone) in rats with hypertension induced by deoxycorticosterone acetate (DOCA) and salt. DOCA pellets were implanted s.c. in male Wistar rats given 0.9% NaCl as drinking solution 3 or 5 weeks before assessment of the effects of i.c.v. injection of RU28318 on cardiovascular and renal functions. Changes in expression of brain angiotensinogen, atrial natriuretic peptide (ANP) and mineralocorticoid receptor mRNA in specific brain areas in 3-week DOCA-salt rats were evaluated by in situ hybridization. The rise in systolic blood pressure induced by DOCA-salt treatment was most marked during the first 3 weeks. At 3 and 5 weeks after implantation of the DOCA-pellets a single i.c.v. injection of 10 ng of RU28318 significantly decreased systolic blood pressure during 24 h as assessed at 2, 8 and 24 h, while heart rate was not altered. Increased urinary excretion of water and electrolytes was observed in 3- and 5-week DOCA-salt rats during the period 0-8 h after i.c.v. injection of RU28318 while the suppressed plasma renin activity was not affected. The expression of brain angiotensinogen, ANP and mineralocorticoid receptor mRNA was not altered by 3-week DOCA-salt treatment, but 3 h after i.c.v. injection of RU28318, mineralocorticoid receptor mRNA expression in hippocampal cell fields responded with an increase of about 40%. In conclusion, these results demonstrate that in rats with hypertension induced by DOCA-salt, brain mineralocorticoid receptor blockade affects renal function and blood pressure regulation.
Subject(s)
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Spironolactone / Blood Pressure / Brain / Mineralocorticoid Receptor Antagonists / Hypertension / Kidney Limits: Animals Language: En Journal: Eur J Pharmacol Year: 2002 Document type: Article Affiliation country: France Country of publication: Netherlands
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Spironolactone / Blood Pressure / Brain / Mineralocorticoid Receptor Antagonists / Hypertension / Kidney Limits: Animals Language: En Journal: Eur J Pharmacol Year: 2002 Document type: Article Affiliation country: France Country of publication: Netherlands